1. Home
  2. KTWOR vs BOLT Comparison

KTWOR vs BOLT Comparison

Compare KTWOR & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KTWOR

K2 Capital Acquisition Corporation Rights

N/A

Current Price

$0.22

Market Cap

9.6M

Sector

N/A

ML Signal

N/A

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$4.28

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTWOR
BOLT
Founded
N/A
2015
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
10.5M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
KTWOR
BOLT
Price
$0.22
$4.28
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$34.00
AVG Volume (30 Days)
307.2K
27.6K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.84
EPS
N/A
N/A
Revenue
N/A
$7,690,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.26
52 Week High
$0.22
$7.35

Technical Indicators

Market Signals
Indicator
KTWOR
BOLT
Relative Strength Index (RSI) N/A 37.82
Support Level N/A $0.28
Resistance Level N/A $5.45
Average True Range (ATR) 0.00 0.40
MACD 0.00 -0.03
Stochastic Oscillator 0.00 16.35

Price Performance

Historical Comparison
KTWOR
BOLT

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: